Veterinary Medicines

Zerofen 222.2 mg/g Granules.

Authorised
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
Zerofen 222.2 mg/g Granules.
Active substance:
  • Fenbendazole
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    22.22
    gram(s)
    /
    100.00
    gram(s)
Pharmaceutical form:
  • Granules
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Foil paper sachets composed of 45 or 50 gsm paper/10 gsm polyethylene/8 um foil/25 gsm polyethylene. The product is packed in 1 g sachets. Sachets containing 1 g are available in the following presentations: 100 x 1 g
  • Foil paper sachets composed of 45 or 50 gsm paper/10 gsm polyethylene/8 um foil/25 gsm polyethylene. The product is packed in 5 g sachets.
  • Foil paper sachets composed of 45 or 50 gsm paper/10 gsm polyethylene/8 um foil/25 gsm polyethylene. The product is packed in 4 g sachets. Sachets containing 4 g are available in the following presentations: 4 x 4 g.
  • Foil paper sachets composed of 45 or 50 gsm paper/10 gsm polyethylene/8 um foil/25 gsm polyethylene. The product is packed in 2 g sachets. Sachets containing 2 g are available in the following presentations: 120 x 2 g .
  • Foil paper sachets composed of 45 or 50 gsm paper/10 gsm polyethylene/8 um foil/25 gsm polyethylene. The product is packed in 2 g sachets. Sachets containing 2 g are available in the following presentations: 70 x 2 g
  • Foil paper sachets composed of 45 or 50 gsm paper/10 gsm polyethylene/8 um foil/25 gsm polyethylene. The product is packed in 1 g sachets. Sachets containing 1 g are available in the following presentations: 120 x 1 g

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent (abridged application) - Council Directive 81/851/EEC
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10987/140/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 23/02/2025
Download

ie-puar-np-600000064247-zerofen-22--granules-en.pdf

English (PDF)
Published on: 23/02/2025
Download